Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech r&d expenses
Research and development expenses are spending on new products and technology.
Stemtech's R&D Expenses for the twelve months ending Sep 30, 2026 was $0. For fiscal 2025 it was $0.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $13.80K | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $0 | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $177 | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $13.80K | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $0 | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $0 | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $0 | – |
See a number that looks wrong?